twitter

Tuesday, 18 December 2012

Cardiac Mortality Is Higher Around Christmas

  • Health Services and Outcomes Research

Cardiac Mortality Is Higher Around Christmas and New Year’s Than at Any Other Time

The Holidays as a Risk Factor for Death

  1. Rosalie R. Phillips, MPH
+ Author Affiliations
  1. From the Departments of Sociology (D.P.P., J.R.J.) and Mathematics (I.S.A.), University of California–San Diego, La Jolla, the San Diego Center for Patient Safety (D.P.P.), and the Tufts Health Care Institute, Tufts University School of Medicine (R.R.P.), Boston, Mass.
  1. Correspondence to David P. Phillips, PhD, Department of Sociology, University of California–San Diego, La Jolla, CA 92093-0533. E-mail dphillips@ucsd.edu

Abstract

Background— Research published in Circulation has shown that cardiac mortality is highest during December and January. We investigated whether some of this spike could be ascribed to the Christmas/New Year’s holidays rather than to climatic factors.
Methods and Results— We fitted a locally weighted polynomial regression line to daily mortality to estimate the number of deaths expected during the holiday period, using the null hypothesis that natural-cause mortality is unaffected by the Christmas/New Year’s holidays. We then compared the number of deaths expected during the holiday period, given the null hypothesis, with the number of deaths observed. For cardiac and noncardiac diseases, a spike in daily mortality occurs during the Christmas/New Year’s holiday period. This spike persists after adjusting for trends and seasons and is particularly large for individuals who are dead on arrival at a hospital, die in the emergency department, or die as outpatients. For this group during the holiday period, 4.65% (±0.30%; 95% CI, 4.06% to 5.24%) more cardiac and 4.99% (±0.42%; 95% CI, 4.17% to 5.81%) more noncardiac deaths occur than would be expected if the holidays did not affect mortality. Cardiac mortality for individuals who are dead on arrival, die in the emergency department, or die as outpatients peaks at Christmas and again at New Year’s. These twin holiday spikes also are conspicuous for noncardiac mortality. The excess in holiday mortality is growing proportionately larger over time, both for cardiac and noncardiac mortality.
Conclusions— Our findings suggest that the Christmas/New Year’s holidays are a risk factor for cardiac and noncardiac mortality. There are multiple explanations for this association, including the possibility that holiday-induced delays in seeking treatment play a role in producing the twin holiday spikes.
Key Words:
Received September 10, 2004; revision received October 29, 2004; accepted November 2, 2004.
Every year, during the Christmas/New Year’s holiday season, millions of Americans abruptly change their patterns of traveling, eating, drinking, exercising, working, and vacationing.1,2 These large-scale behavioral changes may affect cardiac mortality. Some patients might inappropriately delay seeking necessary medical treatment until after the holidays3–7; others who are traveling might take longer than usual to find competent medical help.8 Despite these considerations, we found no previous studies that determined whether the Christmas/New Year’s holiday season affects cardiac (or noncardiac) mortality.
See p 3744
Two bodies of literature are linked to this topic, but only indirectly: (1) Some studies indicate that suicides, homicides, and automobile fatalities increase during the winter holidays,9–11 but these studies do not attempt to determine whether natural-cause mortality also increases during the holiday season. (2) The Christmas/New Year’s holiday season occurs during winter, and the effects of winter on natural-cause mortality have been studied extensively.12–17 These investigations do not attempt to determine whether the winter holiday period has an effect on natural-cause mortality separate from the effects of winter itself.
In the present article, we seek to provide separate measures of these effects. We build on earlier work published in Circulation by Kloner et al,17 who studied daily coronary heart disease (CHD) deaths in Los Angeles, Calif. These authors found that CHD mortality reached an absolute peak “around the winter holiday period,”17 but they did not find separate peaks at Christmas and New Year’s. Kloner et al hypothesized that some of the CHD mortality peak occurred because of behavioral changes, but their study design did not allow them to test this hypothesis. In addition, they made no formal attempt to measure the separate effects on CHD mortality of winter itself versus the winter holiday season.
We investigated questions raised but not answered by Kloner et al17 in this journal: Is there a peak, not only in CHD mortality but also in mortality from other types of heart disease and nonheart diseases? Is there a peak, not only in Los Angeles but also across the entire United States, and is this peak larger in the states with colder climates? How big is the mortality effect of the winter holidays, separate from the effect of winter weather? If there is a holiday peak in cardiac and noncardiac mortality, is the peak growing over time? If there is a holiday peak, can this peak be linked to behavioral changes?
To investigate these questions, we used death certificates to examine daily nationwide mortality. Following Kloner et al,17 we focused on cardiac deaths. In contrast to Kloner et al, we examined both CHD and non-CHD, both heart and nonheart diseases, a larger dataset (n=53 million versus their n=220 000), a longer time period (1973 to 2001 versus their 1985 to 1996), and the United States rather than only Los Angeles.

Methods

The National Center for Health Statistics maintains a computerized administrative database of death certificates. Using this database, which covers all US deaths, we examined daily mortality throughout the year and focused on the “holiday period,” predefined as the 2 weeks from December 25 to January 7. We adopted January 7 as the end point of our study period rather than January 1 because any effects of the holidays on health may take some time to appear. Our study period begins in 1973, the first year for which exact day of death was recorded on all computerized death certificates, and ends in 2001, the last year for which computerized death certificates were available.
We examined all holiday periods between July 1, 1973, and June 30, 2001, with 2 exceptions. The disease classification scheme shifted from ICD-8 to ICD-9 (on January 1, 1979) and from ICD-9 to ICD-10 (on January 1, 1999). These shifts in International Classification of Disease measures produced marked coding changes for some diseases.18 Hence, we did not examine mortality during the Christmas/New Year’s holidays for the transitional periods between classification schemes: July 1, 1978, to June 30, 1979, and July 1, 1998, to June 30, 1999. This procedure abridges the dataset but eliminates a confounding factor, and the dataset remains large at 53 million deaths.
We focused on heart disease but also examined all natural causes of death. In some analyses, we examined death certificates that list both heart disease and additional, secondary causes of death such as influenza; these analyses begin in 1983, the first year in which computerized death certificates listed secondary causes of death.
We fitted a locally weighted polynomial regression (LOESS) line19–21 to daily deaths from January 1, 1973, through December 31, 2001. Use of this standard nonparametric smoothing procedure has several benefits: The procedure makes minimal distributional assumptions about the data, it corrects for the influence of trends and seasonal factors on mortality, and it enables us to estimate the number of deaths that would be expected during the holiday period, given the null hypothesis that natural-cause mortality is unaffected by the Christmas/New Year’s holidays.
The LOESS procedure requires the choice of a bandwidth (roughly speaking, the span of data over which the local averaging takes place). Choosing a bandwidth that is too wide (ie, oversmoothing) would flatten the regression curve near a peak, and would consequently magnify the apparent size of any holiday spike. We proceeded conservatively, choosing a narrow bandwidth of 6 weeks, and thus undersmoothed according to conventional guidelines.19,20 This undersmoothing mitigates any bias in the estimate of excess holiday mortality. As an additional check, we reanalyzed our key findings with an exceptionally conservative bandwidth of 1 week to ensure that our findings remained statistically significant at 0.05 or better. We compared the number of deaths observed during the 2-week holiday period with the number expected under the null hypothesis: 100 × [(observed number of deaths − expected number of deaths) ÷ expected number of deaths].
For convenience, we call this statistic “the holiday effect.” A holiday effect of, for example, 5% would indicate that 5% more deaths occurred during the holiday period than would be expected if the holidays had no effect on mortality.
Following official recommendations22 and our earlier practice,23–30 we calculated standard errors31 and significance levels, even though we examined complete counts, not samples. As in our previous work,23–30 the research design allowed examination of numbers of deaths rather than death rates.

Results

In Figure 1, the solid line indicates the observed number of cardiac deaths for each day of the year, and the dotted line indicates the number of cardiac deaths predicted by the null hypothesis. Aside from the 2-week holiday period, the solid and dotted lines agree closely. For the 351 days outside the holiday period, observed and expected daily mortality levels correlate ≈0.995 (P<0.000001). Thus, our regression procedure corrects well for trends and seasonal influences and accurately predicts cardiac mortality outside the holiday period.
Figure 1. Daily US cardiac deaths, 1973–2001. Solid line indicates the observed number of deaths for each day of the year, summed over the study period (eg, 49 038 total deaths occurred on July 1 for 1973+1974+ … +2001). Dotted regression line indicates the expected number of deaths for each day, given seasonal fluctuations and the null hypothesis that mortality is unaffected by the holidays. Because so many deaths are examined (≈55 000/d), the standard error for each daily count is small (≈235, or 0.4% of the daily count).22 Consequently, the observed number of deaths during the holidays is many standard errors above the number expected under the null hypothesis.
Figure 1 shows 2 distinct spikes in cardiac mortality: one around Christmas and one around New Year’s. Because so many deaths are examined (≈55 000/day), the standard error for each daily count is small (≈235, or 0.4% of the daily count).19 Consequently, the observed number of deaths during the holidays is many standard errors above the number expected under the null hypothesis.
Excess holiday mortality is evident not only when the data-years are summed, as in Figure 1, but also when each data-year is examined separately. We studied holiday mortality in 26 separate years; for 24 of the 26 years, the observed number of deaths during the holidays exceeded the number expected under the null hypothesis (P=0.00001, binomial test). Full details on each year’s holiday effect are provided in the Table.
Size of the Holiday Effect for Cardiac and Noncardiac Mortality, by Year
The percentage excess in holiday mortality has gradually increased during these 26 years. The size of the holiday effect correlates with year of death (Spearman r=0.492; P<0.02, 2-tailed test). In the latest 3 years, observed holiday mortality was 4.4% above the number expected; in the earliest 3 years, holiday mortality was only 0.95% above the number expected.
The excess in cardiac holiday mortality remains statistically significant (both on a year-by-year basis [P<0.05] and for the summed yearly data [P<0.05]) even when an exceptionally conservative bandwidth of 1 week is substituted for the 6-week bandwidth we have used. When a 1-week bandwidth is used, the LOESS regression line exhibits “wiggles,” a classic indication of a bandwidth that is too narrow (details available on request). Thus, the holiday peak, first found by Kloner et al for CHD in Los Angeles,17 is evident nationwide, not only for CHD (2.46% more deaths than expected [SE ±0.12%; 95% CI, 2.22% to 2.69%]) but also for non-CHD deaths (2.81% [SE ±0.25%; 95% CI, 2.32% to 3.30%]).
The double spike on Christmas and New Year’s is particularly striking for cardiac deaths that occur rapidly after presentation of the medical problem (ie, individuals who are dead on arrival [DOA] or die in the emergency department [ED] or as outpatients; Figure 2). For this DOA/ED/outpatient group, more cardiac deaths occur on December 25 than on any other day of the year; the second largest number of cardiac deaths occurs on December 26, and the third largest number occurs on January 1. (A more detailed examination of this double spike is provided later in Figure 6). For inpatients, no obvious double spike occurs on Christmas and New Year’s, although a dispersed spike takes place during the holiday period and just afterward (Figure 3).
Figure 2. Daily US cardiac deaths, 1979–2001, for DOA/ED/outpatients. Solid line indicates the observed number of deaths for each day of the year, summed over the study period. Dotted regression line indicates the expected number of deaths for each day, given seasonal fluctuations and the null hypothesis that mortality is unaffected by the holidays.
Figure 3. Daily US cardiac deaths, 1979–2001, for inpatients. Solid line indicates the observed number of deaths for each day of the year, summed over the study period. Dotted regression line indicates the expected number of deaths for each day, given seasonal fluctuations and the null hypothesis that mortality is unaffected by the holidays.
For DOA/ED/outpatients, 4.65% more cardiac deaths (±0.30%; 95% CI, 4.06% to 5.24%) occur during the holiday period than would be expected from the dotted regression line. For inpatients, this cardiac holiday peak is 1.60% (±0.21%; 95% CI, 1.19% to 2.01%). Information on nursing facility residents is available only for 1989 to 2001 (versus 1979 to 2001 for inpatients and DOA/ED/outpatients). Nursing facility residents also produce a cardiac holiday spike (3.72±0.38%; 95% CI, 2.97% to 4.46%).

Possible Explanations for the Cardiac Holiday Peak

Kloner et al17 proposed that colder temperatures cannot explain the holiday peak because daily CHD mortality correlated only weakly with daily temperatures during December and January in Los Angeles. Our data support their proposition for the following reasons: (1) The climatic hypothesis cannot easily explain the twin mortality spikes on Christmas and New Year’s. (2) The cardiac mortality peak exists after correction for seasonal fluctuations. (3) The cardiac mortality peak is slightly smaller in the northern border states (states that bordered Canada) than in the southern border states (states that bordered Mexico or the Gulf of Mexico) (2.22% versus 3.10%). The cardiac holiday effect pervades the United States, and the size of this effect varies insignificantly from region to region: northeast (2.32%; 95% CI, 1.88% to 2.75%), south (2.66%; 95% CI, 2.29% to 3.03%), midwest (2.29%; 95% CI, 1.87% to 2.72%), and west (2.86%; 95% CI, 2.32% to 3.39%).
Kloner et al proposed but did not test 4 additional explanations, which we assess below.

  • Respiratory diseases. Respiratory diseases increase during winter, and patients weakened by respiratory diseases can die from cardiac diseases. The respiratory hypothesis is undermined by 2 considerations: (1) People dying from cardiac diseases with respiratory disease listed as a secondary cause of death produce a smaller holiday peak than do people dying from cardiac diseases alone: 3.51% versus 3.77%. (2) Interaction between cardiac and respiratory diseases cannot easily explain the twin mortality spikes on Christmas and New Year’s.
  • Emotional stresses associated with holidays. It seems plausible that people with Alzheimer’s disease are less aware of holidays than are people without Alzheimer’s disease. Thus, given the hypothesis that emotional stress is associated with holidays, the holiday peak should be relatively smaller for people dying from cardiac diseases with Alzheimer’s disease listed as a secondary cause of death. The cardiac peak, however, is slightly larger when Alzheimer’s disease is listed as a secondary cause than it is for people dying from cardiac diseases alone: 3.97% versus 3.77%.
  • Changes in diet and alcohol consumption. This explanation is undermined by the following findings: (1) Inpatients, whose diet and alcohol consumption are strictly regulated, produce a holiday peak (Figure 3). (2) People dying from cardiac diseases with substance abuse listed as a secondary cause of death produce a smaller holiday peak than do people dying from cardiac diseases alone: 3.46% versus 3.77%.
  • Increased particulate pollution. The increase in particulate pollution during the winter might be consistent with a general increase in winter mortality, but this hypothesis cannot easily explain the twin mortality spikes on Christmas and New Year’s.

We considered 5 additional explanations not proposed by Kloner et al, as follows.

  • Month boundary effect. Deaths generally peak at the beginning and dip at the end of each month.23 If a “month boundary effect” could explain the holiday peak, then the equivalent of a holiday peak should occur at every month boundary, not only at the December/January boundary. To test this hypothesis, we applied our regression procedure to 11 dummy holiday periods, each centered on a different month boundary (February 1, March 1, etc). For example, instead of using December 25 to January 7 as the holiday period, we substituted January 25 to February 7 as the dummy holiday period, and then re-ran the regression procedure. On average, for the 11 dummy holidays periods, no mortality peak occurred; the observed mortality almost exactly equals the level expected (observed/expected=0.999; SD=0.0023). The mortality peak observed for the real Christmas/New Year’s holiday period is far larger than the peak at any of the other month boundaries. Thus, the month boundary effect cannot account for our findings.
  • Reporting artifact. The holiday peak does not result from misreporting of death dates because the peak is evident for inpatients, whose death dates are particularly likely to be recorded accurately.
  • Postponement of death. Perhaps the holiday peak occurs because some patients postpone death to reach an important occasion.28,29 Given this explanation for the peak, mortality levels should dip immediately before the holiday period, and the preholiday dip should be about the same size as the holiday peak. These expectations are not supported by the evidence shown in Figures 1 through 3. The postponement hypothesis may also be undermined by other data. As noted above, it seems plausible that people with Alzheimer’s disease are generally less likely than others to be aware of the holidays and thus should be less likely than people without Alzheimer disease to try to postpone death to reach these holidays. Thus, given the postponement hypothesis, the holiday peak should be relatively smaller for cardiac patients with Alzheimer’s disease. As noted above, however, this hypothesis is faulty. The cardiac peak is larger when Alzheimer’s disease is listed as a secondary cause than it is for people who die from cardiac diseases alone: 3.97% versus 3.77%.
  • Precipitation of death. Perhaps the holidays merely precipitate some deaths that would have occurred soon anyway. Such precipitation should produce a dip in deaths immediately after the holidays. A dip of this sort is evident but is much smaller than the holiday peak.
  • Inappropriate delay in seeking medical care. Previous studies3–7 show that admissions to urgent care facilities drop on holidays and spike immediately thereafter. This phenomenon may occur because some patients inappropriately delay seeking medical services to avoid disrupting their holidays.3–7 Any holiday-induced delays in seeking medical care should affect not only cardiac deaths but also other deaths. Thus, given the delay-in-seeking-care hypothesis, natural noncardiac deaths also should display a holiday peak. Such a peak is indeed evident, both for DOA/ED/outpatients (Figure 4; 4.99±0.42%; 95% CI, 4.17% to 5.81%) and for inpatients (Figure 5; 1.30±0.14%; 95% CI, 1.03% to 1.57%). The noncardiac holiday peak constitutes an independent replication of the cardiac holiday peak because the death certificates that we used to generate Figures 4 and 5 are entirely different from the death certificates that we used to generate Figures 1 through 3.
       Figure 4. Daily US noncardiac deaths from natural causes, 1979–2001, for DOA/ED/outpatients. Solid line indicates the observed number of deaths for each day of the year, summed over the study period. Dotted regression line indicates the expected number of deaths for each day, given seasonal fluctuations and the null hypothesis that mortality is unaffected by the holidays.
       Figure 5. Daily US noncardiac deaths from natural causes, 1979–2001, for inpatients. Solid line indicates the observed number of deaths for each day of the year, summed over the study period. Dotted regression line indicates the expected number of deaths for each day, given seasonal fluctuations and the null hypothesis that mortality is unaffected by the holidays.

For both cardiac and noncardiac diseases, the holiday peak is most evident for DOA/ED/outpatients. Figure 6 examines DOA/ED/outpatients and provides a magnified view of cardiac and noncardiac mortality during the period immediately surrounding the winter holidays. Both types of mortality display twin holiday peaks, with the peak for Christmas being slightly larger than that for New Year’s. The number of cardiac deaths is higher on December 25 than on any other day of the year, second highest on December 26, and third highest on January 1. The pattern is similar for noncardiac deaths. The number of noncardiac deaths is highest on December 26 than on any other day of the year, the next highest occurs on December 25, and the third highest occurs on January 1.
Figure 6. Daily US cardiac deaths (A) and noncardiac deaths (B), 1979–2001, for DOA/ED/outpatients. Magnified view of the information in Figures 2 and 4 for the period immediately around the Christmas and New Year’s holidays.
We note additional similarities between cardiac and noncardiac mortality during the holiday period. The Table indicates for each year examined the size of the holiday peak for cardiac deaths, noncardiac deaths, and all natural deaths combined. As with cardiac mortality, the percentage excess in noncardiac holiday mortality is gradually increasing during the years under study. The size of the noncardiac holiday peak correlates with the year of death (Spearman r=0.395; P<0.05, 2-tailed test). In the latest 3 years, observed holiday mortality was 2.8% above the number expected; in the earliest 3 years, holiday mortality was only 0.50% above the number expected. For each year, the size of the holiday peak for cardiac mortality is strongly correlated with the size of the holiday peak for noncardiac mortality (r=0.874, t=8.83, P<0.00001). This strong correlation is also evident from the detailed data in Figure 7.
Figure 7. Size of the holiday effect for cardiac and noncardiac mortality by year. Each point on the graph indicates the size of the cardiac holiday peak (x axis) and the size of the noncardiac holiday peak (y axis) for a given year. A strong correlation between the size of the cardiac and noncardiac holiday effects for each year is indicated.
In sum, both cardiac and noncardiac deaths spike during the 2-week holiday period from December 25 through January 7. In the 26 years under study, 42 039 “excess” deaths occurred during this holiday period (95% CI, 39 098 to 44 980). In other words, our findings indicate that during the Christmas/New Year’s holiday periods from 1973 to 2001, ≈42 039 more deaths occurred than would be expected if the holidays did not affect mortality.

Discussion

For cardiac and noncardiac diseases, a spike in daily mortality occurs during the Christmas/New Year’s holiday season. This spike persists after adjusting for trends and seasonal factors and is particularly large for the DOA/ED/outpatient population. For this group during the holiday period, 4.65% (±0.30%; 95% CI, 4.06% to 5.24%) more cardiac deaths and 4.99% (±0.42%; 95% CI, 4.17% to 5.81%) more noncardiac deaths occurred than would be expected if the holidays did not affect mortality. DOA/ED/outpatient cardiac mortality is higher on December 25 than on any other day of the year, second highest on December 26, and third highest on January 1. These twin holiday spikes are also conspicuous for noncardiac mortality.
We considered 10 explanations for the holiday spike. Earlier studies3–7 suggested that some patients delay seeking treatment until after the holidays. These studies did not investigate whether such delays produced additional deaths. Our data suggest that holiday-induced delays in seeking treatment may contribute to additional cardiac and noncardiac deaths around the holidays. Thus, our findings extend the earlier literature by raising the possibility that holiday-induced delays in seeking treatment may have fatal consequences.
Our findings also extend and modify 2 other literatures: (1) European researchers12–15 have found an increase in winter mortality, but they have not sought to determine whether some of this increase results from the winter holidays rather than from winter itself. Future research should seek to disaggregate the effects of winter and the winter holidays. (2) Other research9–11 found that suicides, homicides, and accidents increase on Christmas, New Year’s, or both. This research examined ≈5% of all deaths; our study examined the remaining 95% of deaths and indicates that deaths from natural causes also spike during the holidays.
Delays in seeking treatment could result in sicker patients, some of whom die as inpatients. Thus, the inpatient holiday peak may be consistent with the delay-in-seeking-treatment hypothesis. This hypothesis, however, cannot easily explain the holiday peak in nursing facility residents’ deaths (3.72±0.38%; 95% CI, 2.97% to 4.46%). Some other processes may also play a role—for example, changes in medical staffing during the holidays.32,33 Future research should investigate the potential effect of these staff changes.
The epidemiological data used in this article are appropriate for examining a large (n>53 million), nationwide, multiyear dataset and for demonstrating the existence of a previously unknown double spike in cardiac and noncardiac mortality; however, our data are not appropriate for definitively identifying the detailed causes of this double spike. Future investigations should seek an answer to this question and to additional questions raised by the data in the Table and in Figure 7. For example, cardiac holiday peaks occurred in 24 of the 26 years under study but not in 1973 or 1981. Was this a fluke or are these years unusual in some way? The Organization of Petroleum-Exporting Countries’ embargo on exporting petroleum products to the United States and other countries included the holiday period from December 25, 1973, to January 7, 1974. Travel during the embargo was markedly reduced,34 and it also was reduced during the recession of 1981.35 If the holiday effect occurs in part because of delays in seeking medical treatment by travelers, then a reduction in travel may produce a reduction in the holiday effect. Future research should assess this possibility.
Potential explanations for the holiday effect need to be assessed further in follow-up investigations with different types of datasets, which provide more details on patients and their circumstances. In comparison with the large-scale dataset we have used, these follow-up datasets are likely to be richer in detail but more limited in size, geographic area, and time period. Even before these follow-up studies are performed, however, the current evidence seems sufficient to demonstrate that the Christmas/New Year’s holiday season is a risk factor for both cardiac and noncardiac mortality. Because this risk factor is growing with time, it seems particularly important to investigate it and control it.

Acknowledgments

Dr David P. Phillips conceived the idea for the study and conducted the analyses. Dr Ian S. Abramson determined the appropriate LOESS bandwiths and helped ensure the statistical integrity of the study. Jason R. Jarvinen conducted the literature review. Dr David P. Phillips, Jason R. Jarvinen, Dr Ian S. Abramson, and Rosalie R. Phillips contributed equally to the interpretation of data and the writing and revising of the article. The authors thank Evelyn and Robert Kleinberg, Christy G. Kwan, Kevin Lewis, and Miranda and Rachel Phillips for useful comments.

References

Articles citing this article

Monday, 17 December 2012

The American Wind Energy Association released an analysis on Wednesday, detailing how the wind industry could phase out reliance on federal tax credits over a six-year time period. In contrast to the wind industry's bold move, there is no end in sight for the fossil fuel subsidies that polluting industries have enjoyed for almost 100 years. Indeed, while the fledgling wind industry was able to develop a plan for moving off of subsidies after just two decades, the fossil fuel industries continue adding to our national debt by taking billions of taxpayer dollars to pollute our air and water. The wind industry has taken the first steps toward moving off of federal subsidies, and it is past time the fossil fuel industry did the same. via sierraclub.typepad.com

The American Wind Energy Association released an analysis on Wednesday, detailing how the wind industry could phase out reliance on federal tax credits over a six-year time period. In contrast to the wind industry's bold move, there is no end in sight for the fossil fuel subsidies that polluting industries have enjoyed for almost 100 years. Indeed, while the fledgling wind industry was able to develop a plan for moving off of subsidies after just two decades, the fossil fuel industries continue adding to our national debt by taking billions of taxpayer dollars to pollute our air and water. The wind industry has taken the first steps toward moving off of federal subsidies, and it is past time the fossil fuel industry did the same.
via sierraclub.typepad.com

Ernest Mario School of Pharmacy - Rutgers University Summer Research Fellowship Program

Posted: 16 Dec 2012 10:10 AM PST
Ernest Mario School of Pharmacy - Rutgers University Summer Research Fellowship Program
The Ernest Mario School of Pharmacy announces the 2013 Summer Undergraduate Research Fellowship (SURF) Program. The program is intended for highly motivated undergraduates interested in a research career in the pharmaceutical and environmental sciences. Students are provided with an opportunity to conduct full-time research in areas related to Pharmacology and Toxicology, Environmental Health Sciences, Pharmaceutics, Medicinal Chemistry, Chemical Biology, and Clinical Pharmacy. The SURF program is open to undergraduate students currently enrolled at a university in the United States. Previous experience performing independent laboratory or clinical research is not required. Students should be sophomores, juniors, or seniors at the time of application.
This 10-week program will run May 20 through July 26, 2013 and provides a $2,800 stipend. Students must be available for the entire 10-week period. Training includes hands-on research conducted in the laboratories or clinical practices of faculty members, round table discussions of research progress, and seminars on research careers and activities of the faculty.  Students also participate in career development workshops. At the end of the fellowship, each student will provide a brief oral presentation on his or her summer research project.
To apply to the Summer Research Fellowship Program, the following items are required:
·  Completed application form
·  College transcripts (current and previously attended universities)
·   Personal statement
·   Letter(s) of recommendation (only 1 letter is required)
Applications must be typed and submitted in a single envelope. Letter(s) of recommendation should be in sealed envelopes and included in the envelope with the completed application form, transcripts, and personal statement. All application materials must be received/postmarked by February 6, 2013. Only complete applications will be reviewed.
Students are responsible for finding local housing for the 10-week duration of the SURF program.  Additional funding for room and board is not available. All questions concerning summer housing should be directed to the Residence Life Assignments Office at oncampus@rci.rutgers.edu or (732) 445-0750.
For further information, please contact Dr. Debra Laskin by email at laskin@eohsi.rutgers.edu or Dr. Lauren Aleksunes at aleksunes@eohsi.rutgers.edu.  Students selected for the program will begin to be notified March 8, 2013. Students will have 1 week to notify the Program of their intent to participate. Notifications of selected students will be made through April 1, 2013.  Students who are not selected will be notified by April 8, 2013.
Note: Pharmacy students selected for the SURF program will be placed into Cycle III for their pharmacy practice experience.
Send completed applications to:
Ms. Cindy Olexsa
Dean’s Office
Ernest Mario School of Pharmacy
Rutgers University
160 Frelinghuysen Road
Piscataway, NJ   08854
The SURF Program at the Ernest Mario School of Pharmacy is financially supported by the National Institute of Environmental Health Sciences (1R25ES020721), the American Society for Pharmacology and Experimental Therapeutics, the UMDNJ Graduate School of Biomedical Sciences, and the Dean of the School of Pharmacy.
General Research Areas
Pharmacology, Toxicology and Environmental Health Sciences: neurotoxicology; immunology; inflammatory mechanisms of tissue injury; kidney injury; role of extracellular matrix in development and disease pathology; wound healing; nitric oxide biology; pulmonary toxicology, developmental toxicology; environmental health sciences
Medicinal Chemistry: design and synthesis of enzyme inhibitors and prodrugs; synthetic organic chemistry, structure activity relationships, medicinal chemistry
Pharmaceutics: design, development and evaluation of drug delivery systems; biopharmaceutics (drug formulation, drug transport); pharmacokinetics
Chemical Biology: cancer biology and prevention; regulation of tumor cell growth and differentiation
Pharmacy Practice: clinical studies; diabetes, hypertension, and medication therapy management
Posted: 16 Dec 2012 10:01 AM PST
Call for Applications: Association of Community Health Nursing Educators Research Grant
Once again ACHNE is sponsoring funding for a research grant. The purpose of this funding is to provide seed money, pilot funding, or total funding for small studies with promising contributions to public health nursing (PHN) or PHN education.
The applicant must be a member of ACHNE, have a master’s or doctoral degree or enrolled in a doctoral program.
The maximum amount of funding will be $5,000. Funds will be awarded at the ACHNE Annual Institute. Proposals must be submitted by February 1, 2013 to Dr. Barbara Polivka at polivka.1@osu.edu.  Contact Dr. Barbara Polivka at polivka.1@osu.edu with questions.

Friday, 14 December 2012

innovative Section Traditional, Complementary and Alternative Medicine in Predictive, Preventive and Personalised Medicine (PPPM)


I have the pleasure to most warmly invite you to publish in the EPMA Journal.

I have launched the innovative Section Traditional, Complementary and Alternative Medicine in Predictive, Preventive and Personalised Medicine (PPPM) http://www.epmajournal.com/sections/tcam 

Traditional, Complementary and Alternative Medicine in PPPM Section edited by Paolo Roberti di Sarsina

* This section provides a platform for scientific publications demonstrating how ?Traditional, Complementary and Alternative Medicine (TCAM)? can enrich the paradigm of Predictive, Preventive and Personalized Medicine.
* Evidence-based TCAM scientific approaches should demonstrate high levels of person centred and participatory medicine, functional links between TCAM, predictive diagnostics, targeted prevention and individualised treatments in healthcare education and clinical practice.
* Topics should explore tailoring care by investigating and treating the person as a physical, psychological and spiritual unicum living in dynamic interaction with nature and society.
* Individualising the therapeutic process by renewing the caregiver-person relationship with trust, compassion and respect for personal choices.
* Exploring innovative research methods to evaluate TCAM and other salutogenetic interventions as a form of preventive medicine empowering communities and individuals.

Hoping of some interest for you here is the link to Traditional, complementary and alternative medical systems and their contribution to personalisation, prediction and prevention in medicine---person-centred medicine which is the inaugural open-access article http://www.epmajournal.com/content/pdf/1878-5085-3-15.pdf of the section

Thursday, 13 December 2012

Role of Mediterranean diet, tropical vegetables rich in antioxidants, and sunlight exposure in blindness, cataract and glaucoma among African type 2 diabetics

Int J Ophthalmol. 2012; 5(2): 231–237.
Published online 2012 April 18. doi: 10.3980/j.issn.2222-3959.2012.02.23
PMCID: PMC3359045

Role of Mediterranean diet, tropical vegetables rich in antioxidants, and sunlight exposure in blindness, cataract and glaucoma among African type 2 diabetics

Abstract

AIM

To assess whether regular Mediterranean diet and regular intake of vegetables may reduce the risk of blindness, cataract, and glaucoma in these type 2 diabetics.
Fruits and vegetables contain a vast array of antioxidant components, mainly polyphenols and flavonoids such as anthocyanins[13],[14]. Flavonoids possess several physiological properties: antioxidant, antibacterial, antiviral, anti-inflammatory, anti mutagenic and antitumor activity, as well as the activation or inactivation of certain enzymes[15]. The researchers found that several flavonoids can prevent cell death at low concentrations; other flavonoids have limited or no effect. Quercetin, a flavonoid present at higher concentrations in yellow onions, prevents oxidative stress-induced cell death in retinal pigmentary epithelium (RPE) cells and has no cellular toxicity over a wide range of concentrations.
Dietary antioxidants prevent cataract formation by preventing oxidation of proteins or lipids within the lens in general and during aging also related to oxidative stress and cataract genesis[16],[17].

METHODS

A cross-sectional design was carried out among known black diabetics admitted at the diabetic clinics of Kinshasa, between October 2008 and March 2009. The Mediterranean-style dietary score (MSDPS) was used to characterize a Mediterranean-style dietary pattern in the study population using the Harvard semi quantitative FFQ adapted for Africa.

RESULTS

Five hundred Type 2 diabetic patients were included in this study (48% of males; 40% aged ≥60 years). There was a significant association between blindness, cataract and aging; between blindness (P<0.05), cataract (P<0.05), glaucoma (P<0.05), and physical inactivity; between blindness (P<0.05), cataract (P<0.0001), glaucoma (P<0.01) and high SES, and a very significant association between blindness (P<0.0001), cataract (P<0.0001), glaucoma (P<0.0001) and exposure to sunlight. There was also a significant association between blindness, glaucoma, and male sex. Regular intake of Mediterranean diet, Brassica Rapa, beans, Abelmoschus, Musa acuminata reduced significantly the risk of blindness, cataract and glaucoma.
The present study showed that regular Mediterranean Diet as well as regular intake of vegetables reduced the risk of blindness, cataract, and glaucoma in these type 2 diabetics. These findings highlighted a very low rate of consumption of vegetables in Africa[27]. Indeed, fruits are only eaten by children in general and diabetics are always discouraged to eat fruits by popular believes.
The present study is, to our knowledge, the first survey focussed on the effects of Mediterranean diet among African type 2 diabetics. The protection against chronic diabetes complications such as cataract, blindness, and glaucoma observed in this study may be explained by the significant reduction in cellular lipids level, and LDL oxidation (oxidative stress) reported by many researchers on Mediterranean diet[9],[28]. This protective action has also been attributed to the higher level in antioxidants in Mediterranean diet[29],[30]. The antioxidant capacity from olive oil, flavonoids, fruits, vegetables, and red wine, the main components of Mediterranean diet[9],[13],[14],[20] are supposed to counter the pro-oxidant of aging, age-related ocular diseases (age-related macular degeneration, diabetic retinopathy, glaucoma, cataract). Indeed, the pathogenetic mechanisms in this diabetic eye complication are the deficiency of antioxidant system, and the chronic hyperglycaemia-related overproduction of free radicals precursors[10]-[12]. The antioxidant effects of the Mediterranean diet have also been reported to prevent atherosclerosis[30], cancer, and other mortalities.
The other significant protective factors against blindness, cataract, and glaucoma were regular intake of Brassica rapa (pointe noire), Phaseolus vulgaris (dry beans), Abelmoschus esculentus (gombo), and Musa acuminata (plantains). Brassica rapa is rich in polysaccharides (BRP1-1, BRPé-1, BRP3-1) which are known with a novel potential anti-hypoxia agent[31]. The antiradical activity of dry beans (Phaseolus vulgaris) is well known[32]. Dry beans considered to have the highest total antioxidant capacity[33]-[37] were recently identified as significant and independent protective factor against Metabolic syndrome (MetS) in African type 2 diabetics[27]. Abelmoschus esculentus Moench (gombo), often eaten in the North of Nigeria is characterized by antioxidant activities[38]. The ferric-reducing antioxidant power FRAP), and oxygen radical absorbance capacity (ORAC), markers of antioxidant capacity are reported in different varieties of Musa acuminata[39].
However, despite the intake of antioxidants from Mediterranean diet and locally grown vegetables, aging, usually inducing oxidative stress, was identified as a significant risk factor of both blindness and cataract among these diabetics.
Physical inactivity accompanied by a low grade inflammatory status was identified as a significant risk factor of blindness, cataract, and glaucoma. And a very significant association was shown between blindness, cataract, glaucoma, and exposure to sunlight by professions. Those results confirm the role of environmental factors in inducing the DNA damage, heart shock, apoptosis and oxidative stress. Indeed, after rural-urban migration, these type 2 diabetics are exposed to epidemiologic, demographic, and nutrition transition, with subsequent consequences such as obesity, inappropriate diet (high salt, fat, sugar, cigarette, and alcohol consumption)[40]-[44].
In general, primary metabolites of plants rich in antioxidants (carbohydrates, proteins, amino acids, lipids) are essential for cells survival and propagation[45]. The secondary metabolites from plants function in defence against predators and abiotic stresses like UV sunlight.
Indeed, we know that free radical-driven, molecular and cellular processes modulated by phenylpropanoid (antioxidants) in human cells cultures in vitro and in the in vivo animal models of tumours, inflammation, and cellular damage are reported in the literature[45]-[46].
These findings have several strengths such as new insights on oxidative stress and ocular diabetic complications that may lead to a casual antioxidant therapy[47] and health promotion. Thus, exercise, smoking cessation, moderate alcohol intake, and protection against sunlight are the background to curve the rising epidemic of type 2 diabetes and ocular complications in these Africans.
Health professionals could educate African diabetics in general and African male diabetics in particular, and prescribe them supplements rich in antioxidants[48] in terms of primary prevention. Globally, and in sub-Saharan Africa, after adjusting for age, the female sex is significantly associated with blindness and major causes of blindness because of low coverage and poverty[49]-[51]. In the present study and in other African studies[1],[2],[8],[18],[41],[52]-[56], the diabetic African men are more susceptible to blindness and glaucoma and their causes such as hypertension, diabetic retinopathy, cataracts, cigarette smoking, low intake of vegetables-fruits, overrepresentation in hospital series because of income, and late admissions.
In the poor African context, both men and women with blindness lack awareness of the potential to cure these conditions, lack access to services, or do not accept services for a variety of cultural and social reasons. These issues prevent both women and men from availing the services they need but affect them differently[49]. The issue of late presentation has not improved over the last three decades[56].
The present study was limited because of its cross-sectional design which is not capable to demonstrate a casual association between the identified determinants and ocular diabetes complications. Indeed, only prospective studies can do that.
Endogenous markers of oxidative stress and antioxidants were not measured in blood samples. However, potential bias and confounding factors were reduced by the large size of participants and the use of the multivariate logistic regression.
In conclusion, both regular intake of the Mediterranean Diet and the consumption of locally grown vegetables including Brassica Rapa, dry beans, Abelmoschus esculentus, and Musa acuminata rich in antioxidants could exert significant protective effects on blindness, cataract, and glaucoma development in type 2 diabetics. Thus, the present data provide evidence to recommend supplement in antioxidants as useful tools against type 2 diabetes mellitus and its ocular complications. Aging, higher SES, male sex, physical inactivity, and exposure to sunlight were identified as risk factors of ocular diabetic complications.

 

Wednesday, 12 December 2012

Quantitative analysis of antiradical phenolic constituents from fourteen edible Myrtaceae fruits

Food Chem. Author manuscript; available in PMC 2011 February 16.
Published in final edited form as:
Food Chem. 2008 August 15; 109(4): 883–890.
doi:  10.1016/j.foodchem.2008.01.021
PMCID: PMC3040238
NIHMSID: NIHMS47435

Quantitative analysis of antiradical phenolic constituents from fourteen edible Myrtaceae fruits

Abstract

Many species of Myrtaceae are cultivated in home gardens throughout the tropics for their edible fruit, and have been used in traditional medicine to treat several inflammatory conditions. Fruit phenolics are important dietary antioxidant and anti-inflammatory constituents. We have investigated the antiradical activity, total phenolic content (TPC), and total anthocyanin content (TAC) of 14 underutilized Myrtaceae fruits, namely Eugenia aggregata, E. brasiliensis, E. luschnathiana, E. reinwardtiana, Myrciaria cauliflora, M. dubia, M. vexator, Syzygium cumini, S. curranii, S. jambos, S. javanicum, S. malaccense, S. samarangense, and S. samarangense var. Taiwan pink. An HPLC-PDA method was developed to quantify the amounts of cyanidin 3-glucoside (1), delphinidin 3-glucoside (2), ellagic acid (3), kaempferol (4), myricetin (5), quercetin (6), quercitrin (7), and rutin (8) present in MeOH extracts of the fruit. TPC ranged from 3.57 to 101 mg/g, TAC ranged from undetectable to 12.1 mg/g, and antiradical activity, measured as DPPH˙ IC50, ranged from very active (19.4 μg/ml) to inactive (389 μg/ml).
Keywords: HPLC-PDA, quantitative analysis, Myrtaceae, Myrciaria, Eugenia, Syzygium, antioxidant, flavonoid, anthocyanin, Folin-Ciocalteu, DPPH, polyphenolic

1. Introduction

According to the Centers of Disease Control and Prevention, over half of all deaths in the United States are caused by diseases of the heart and malignant neoplasms (Minino, Heron & Smith, 2006). Epidemiological evidence suggests that diets high in fruits and vegetables are linked to a reduced incidence of heart disease, cancer, and some neurodegenerative disorders (Youdim & Joseph, 2001; Hu & Willett, 2002; Arts & Hollman, 2005; Collins, 2005). Reactive oxygen species (ROS) are produced naturally in mammalian systems as a result of oxidative metabolism. However, ROS damage cell membranes and DNA, causing cancerous mutations, and the oxidation of low-density lipoprotein is a major factor in the promotion of heart disease. ROS are also implicated in activating redox-responsive pro-inflammatory transcription factors, nuclear factor (NF)-κB and activator protein (AP)-1 (Rahman & Adcock, 2006). Inflammation is a major factor in the promotion of chronic inflammatory diseases, as well as the etiology of cancers and heart disease (Middleton, Kandaswami & Theoharides, 2000; Hu et al., 2002). Oxidative damage is balanced by endogenous antioxidants, but additional protection, provided by nutritive and non-nutritive elements from food, is critical for disease chemoprevention.
Colourful fruits are a potentially rich source of many dietary phenolic antioxidants and are believed to play an important role in the prevention of many oxidative and inflammatory diseases (Arts et al., 2005). The anthocyanin pigments are responsible for many of the bright fruit and flower colours, and act as strong antioxidants and anti-inflammatories, with antimutagenic and cancer chemopreventative activities (Kong, Chia, Goh, Chia & Brouillard, 2003; Reynertson et al., 2006). Anthocyanins often account for much of the phenolic content of these fruits, but flavanols, procyanidins, phenolic acids, and ellagitannins may be the most predominant phenolics in some taxa. Polyphenolic compounds inhibit several oxidative and inflammatory enzymes (Middleton et al., 2000), and have shown antiallergenic, antiviral, antibacterial, antifungal, antitumor, and antihemorrhagic activities (Pietta, 2000). Flavonoids also inhibit the inflammatory transcription factors NF-κB and AP-1 (Rahman et al., 2006).
The plant family Myrtaceae is pan-tropical in occurrence, with concentrations in South America, Southeast Asia, and Australia. The fleshy-fruited subfamily, Myrtoideae, includes many economically important food plants, agricultural crops, and ornamentals, including the Mediterranean genus Myrtus (myrtle), spices such as clove (Syzygium aromaticum), allspice (Pimenta dioica), and bay rum (Pimenta racemosa), and the fruits of Psidium (guavas), Myrciaria, Eugenia, Syzygium, Plinia and Luma.
In this report, we have analyzed the phenolic content and antiradical activity of 14 edible fruits from 13 species of Myrciaria, Eugenia and Syzygium, namely Eugenia aggregata Kiaersk., E. brasiliensis Lam., E. luschnathiana Klotzsch ex O.Berg, E. reinwardtiana (Bloom) DC, Myrciaria cauliflora (Mart.) O.Berg, M. dubia (Kunth) McVaugh, M. vexator McVaugh, Syzygium cumini (L) Skeels, S. curranii (C.B.Rob.) Merr., S. jambos (L) Alston, S. javanicum Miq., S. malaccense (L)Merr. & L.M.Perry, S. samarangense (Bloom) Merr. & L.M.Perry and S. samarangense var. Taiwan pink.
These fruits are mostly red to purple drupes, 2-4 cm in diameter, although some species produce larger or less pigmented fruit. In the tropics, these species are often cultivated in home gardens, small-scale agricultural plots, or wild-harvested. They are primarily eaten fresh or used to make jams, desserts, wines, liquors, and vinegars, and can be found in local markets. In addition to their use as food, many of these fruits have been used in divergent traditional medical practices for a variety of illnesses and conditions. Most notably, the seeds of the jamun (S. cumini) are an important Ayurvedic medicine for diabetes. The rose apple (S. jambos) has been used in India as a tonic for the brain and for liver problems, as an astringent, and digestive (Kirtikar & Basu, 1988), and distilled to make rosewater (Morton, 1987). In Brazil, E. brasiliensis leaves have been used for gastrointestinal disorders and rheumatism, and the jaboticaba fruit (M. cauliflora) has been used as a treatment for hemoptysis, asthma, diarrhea, and chronic inflammation of the tonsils (Morton, 1987). Leaves of S. malaccense have been used for a wide variety of inflammatory conditions in Western Samoa (Andersson Dunstan, Noreen, Serrano, Cox, Perera & Bohlin, 1997).
The majority of the phytochemical literature for these species has focussed on the aromatic terpenoid compounds found in the leaves (Wong & Lai, 1996), but phenolics have also been identified in some species. We previously reported flavonols, phenolic acids, anthocyanins, and depsides from M. cauliflora (Reynertson et al., 2006), as well as the occurrence of catechin and epicatechin in E. aggregata (Reynertson, Basile & Kennelly, 2005). Myrciaria dubia was reported to contain cyanidin 3-glucoside and delphinidin 3-glucoside (Zanatta, Cuevas, Bobbio, Winterhalter & Mercadante, 2005). Several flavonoids, ellagitannins, and phenolic acids have been identified from the fruits, seeds, and aerial parts of S. cumini (Bhatia, Bajaj & Ghangas, 1971; Bhatia & Bajaj, 1975; Mahmoud, Marzouk, Moharram, El-Gindi & Hassan, 2001), and flavonoids and ellagitannins have been found in the fruits of S. samarangense (Okuda, Yoshida, Hatano, Yazaki & Ashida, 1982; Nonaka, Aiko, Aritake & Nishioka, 1992; Srivastava, Shaw & Kulshreshtha, 1995; Nair, Krishnan, Ravikrishna & Madhusudanan, 1999). Ellagic acids and an anthocyanin were reported from S. malaccense (Andersson Dunstan et al., 1997). To the best of our knowledge, however, the phenolic constituents of Eugenia brasiliensis, E. luschnathiana, E. reinwardtiana, Myrciaria vexator, Syzygium curranii, S. javanicum, and S. samarangense var. Taiwan pink have not been reported in the literature, despite their widespread consumption in the tropics.
Here we report on the HPLC-PDA quantification of eight phenolic compounds in 14 fruits. Cyanidin 3-glucoside (1), delphinidin 3-glucoside (2), ellagic acid (3), kaempferol (4), myricetin (5), quercetin (6), quercitrin (7), and rutin (8) .

With cancers and heart disease being the leading causes of death in the United States, studies indicate that diets high in naturally occurring antioxidants and anti-inflammatories are important as a first-line strategy of chemoprevention (Youdim et al., 2001; Hu et al., 2002; Arts et al., 2005; Collins, 2005). We have shown that edible fruits in the Myrtaceae are a rich source of biologically active phenolic compounds, which is similar to other well-studied berries and fruits (Kähkönen et al., 2001).

Tuesday, 11 December 2012

Why is the Failed Monti a “Technocrat” and the Successful Correa a “Left-Leaning Economist”?

Bill Black: Why is the Failed Monti a “Technocrat” and the Successful Correa a “Left-Leaning Economist”? http://www.nakedcapitalism.com/ By Bill Black, the author of The Best Way to Rob a Bank is to Own One and an associate professor of economics and law at the University of Missouri-Kansas City. Cross posted from New Economic Perspectives The New York Times produces profiles of national leaders like Italy’s Mario Monti and Ecuador’s Rafael Correa. I invite readers to contrast the worshipful treatment accorded Monti with the Correa profile. The next time someone tells you the NYT is a “leftist” paper you can show them how far right it is on financial issues. Read the Rest... Read more at http://www.nakedcapitalism.com/#4fQjWtVmKZ7Cxw7d.99

Pressurized liquid extraction of ginger (Zingiber officinale Roscoe) with bioethanol: an efficient and sustainable approach.

J Chromatogr A. 2011 Aug 26;1218(34):5765-73. doi: 10.1016/j.chroma.2011.06.088. Epub 2011 Jul 3.

Pressurized liquid extraction of ginger (Zingiber officinale Roscoe) with bioethanol: an efficient and sustainable approach.

Source

Department of Molecular Biology, Aarhus University, Gustav Wieds Vej 10, 8000 Aarhus, Denmark.

Abstract

To develop an efficient green extraction approach for recovery of bioactive compounds from natural plants, we examined the potential of pressurized liquid extraction (PLE) of ginger (Zingiber officinale Roscoe) with bioethanol/water as solvents. The advantages of PLE over other extraction approaches, in addition to reduced time/solvent cost, the extract of PLE showed a distinct constituent profile from that of Soxhlet extraction, with significantly improved recovery of diarylheptanoids, etc. Among the pure solvents tested for PLE, bioethanol yield the highest efficiency for recovering most constituents of gingerol-related compounds; while for a broad concentration spectrum of ethanol aqueous solutions, 70% ethanol gave the best performance in terms of yield of total extract, complete constituent profile and recovery of most gingerol-related components. PLE with 70% bioethanol operated at 1500 psi and 100 °C for 20 min (static extraction time: 5 min) is recommended as optimized extraction conditions, achieving 106.8%, 109.3% and 108.0% yield of [6]-, [8]- and [10]-gingerol relative to the yield of corresponding constituent obtained by 8h Soxhlet extraction (absolute ethanol as extraction solvent)

Monday, 10 December 2012

Sorrel drink lowers blood pressure

J Nutr. 2010 Feb;140(2):298-303. Epub 2009 Dec 16.

Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults.

Source

Antioxidants Research Laboratory; 6Energy Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA. diane.mckay@tufts.edu

Abstract

In vitro studies show Hibiscus sabdariffa L., an ingredient found in many herbal tea blends and other beverages, has antioxidant properties, and, in animal models, extracts of its calyces have demonstrated hypocholesterolemic and antihypertensive properties. Our objective in this study was to examine the antihypertensive effects of H. sabdariffa tisane (hibiscus tea) consumption in humans. A randomized, double-blind, placebo-controlled clinical trial was conducted in 65 pre- and mildly hypertensive adults, age 30-70 y, not taking blood pressure (BP)-lowering medications, with either 3 240-mL servings/d of brewed hibiscus tea or placebo beverage for 6 wk. A standardized method was used to measure BP at baseline and weekly intervals. At 6 wk, hibiscus tea lowered systolic BP (SBP) compared with placebo (-7.2 +/- 11.4 vs. -1.3 +/- 10.0 mm Hg; P = 0.030). Diastolic BP was also lower, although this change did not differ from placebo (-3.1 +/- 7.0 vs. -0.5 +/- 7.5 mm Hg; P = 0.160). The change in mean arterial pressure was of borderline significance compared with placebo (-4.5 +/- 7.7 vs. -0.8 +/- 7.4 mm Hg; P = 0.054). Participants with higher SBP at baseline showed a greater response to hibiscus treatment (r = -0.421 for SBP change; P = 0.010). No effects were observed with regard to age, gender, or dietary supplement use. These results suggest daily consumption of hibiscus tea, in an amount readily incorporated into the diet, lowers BP in pre- and mildly hypertensive adults and may prove an effective component of the dietary changes recommended for people with these conditions.

Free full text

Friday, 7 December 2012

coyote?

After some weeks of not seeing anything el gato and I saw the old raccoon and the light footed bushy tailed animal that I think is probably a coyote. Surprisingly we saw both after 6 am. The coyote like the last time was coming down the side road but it turned down our lane. For once el gato saw it before it saw us and ran back inside with a growl. Then it saw me, stopped and turned sideways for a minute as if it was considering before it decided to take another route.

Thursday, 6 December 2012

Community-based harassment is a grown-up version of school yard bullying.

A group of people who don't know you when you are looking for a job, don't contribute to your interests and don't even talk to you know what you are looking for in a man? How likely is that? Disrespectful and delusional and extremely sexist. The purpose of a supermarket is to buy food and the library is for scholarly work. http://www.randomcollection.info/catchcanada/ Community-based harassment is a grown-up version of school yard bullying. Multiple individuals within a community participate in the harassment and stalking of a single individual. However, rather than attack a victim physically, techniques are used to undermine a person psychologically. This can be far more damaging than a physical attack because not only is it very hard to prove, but it is extremely traumatizing for the victim. (Also known as cause stalking or gang stalking). What sets community-based harassment apart from the related examples to the right is that the reason it takes place is often obscure to the victim. Without a solid reason for its occurrence, victims are often dismissed as delusional. In addition, this form of harassment often leaves the target a victim of ridicule among friends and family because of the subtle nature of the attacks, which further compounds the trauma to the victim. It is emotionally draining and isolating to the victims because it is extremely difficult to prove, and virtually impossible . ________________________________________ Why is this Happening? ________________________________________ Although it is difficult for a non-victim to understand, it is not difficult to realize that many schoolyard bullies have never outgrown their unhealthy ways of dealing with conflict and pain. Reasons may include revenge by people who feel slighted but prefer to remain anonymous. Revenge is more common than you may think, especially with the advent of the internet which allows "revengists" or "avengers" to share their ideas. See http://www.ekran.no/html/revenge/ or do a search on the word "revenge" to see for yourself. It is also possible that such harassment has developed into a form of "sport" for the individuals who participate, not unlike a schoolyard bullying situation, which tends to center somewhat obsessively and irrationally around one individual who is perceived to be weak. It is important to realize that our society's understanding of human psychology has grown exponentially over the last 50 years, allowing any hate or vigilante group to take full advantage of such knowledge. "Psychological warfare" is the perfect crime, because it causes the maximum damage to the victim, with the least chance of exposure of the perpetrator(s). Victims can very well be driven to suicide, while the explanation appears to be mental illness, so their claims are never investigated.